Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2016 Jan;23(2):194-205.
doi: 10.1177/2047487314560664. Epub 2014 Nov 21.

Inflammatory markers and extent and progression of early atherosclerosis: Meta-analysis of individual-participant-data from 20 prospective studies of the PROG-IMT collaboration

Affiliations
Meta-Analysis

Inflammatory markers and extent and progression of early atherosclerosis: Meta-analysis of individual-participant-data from 20 prospective studies of the PROG-IMT collaboration

Peter Willeit et al. Eur J Prev Cardiol. 2016 Jan.

Abstract

Background: Large-scale epidemiological evidence on the role of inflammation in early atherosclerosis, assessed by carotid ultrasound, is lacking. We aimed to quantify cross-sectional and longitudinal associations of inflammatory markers with common-carotid-artery intima-media thickness (CCA-IMT) in the general population.

Methods: Information on high-sensitivity C-reactive protein, fibrinogen, leucocyte count and CCA-IMT was available in 20 prospective cohort studies of the PROG-IMT collaboration involving 49,097 participants free of pre-existing cardiovascular disease. Estimates of associations were calculated within each study and then combined using random-effects meta-analyses.

Results: Mean baseline CCA-IMT amounted to 0.74 mm (SD = 0.18) and mean CCA-IMT progression over a mean of 3.9 years to 0.011 mm/year (SD = 0.039). Cross-sectional analyses showed positive linear associations between inflammatory markers and baseline CCA-IMT. After adjustment for traditional cardiovascular risk factors, mean differences in baseline CCA-IMT per one-SD higher inflammatory marker were: 0.0082 mm for high-sensitivity C-reactive protein (p < 0.001); 0.0072 mm for fibrinogen (p < 0.001); and 0.0025 mm for leucocyte count (p = 0.033). 'Inflammatory load', defined as the number of elevated inflammatory markers (i.e. in upper two quintiles), showed a positive linear association with baseline CCA-IMT (p < 0.001). Longitudinal associations of baseline inflammatory markers and changes therein with CCA-IMT progression were null or at most weak. Participants with the highest 'inflammatory load' had a greater CCA-IMT progression (p = 0.015).

Conclusion: Inflammation was independently associated with CCA-IMT cross-sectionally. The lack of clear associations with CCA-IMT progression may be explained by imprecision in its assessment within a limited time period. Our findings for 'inflammatory load' suggest important combined effects of the three inflammatory markers on early atherosclerosis.

Keywords: Inflammation; atherosclerosis; meta-analysis.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest

SA has received speaker’s honoraria from Sanofi, Siemens, Pfizer, Boehringer-Ingelheim, Orion Pharma, and Astra Zeneza and is on the advisory board for Astra Zeneca. OHF works in ErasmusAGE, a centre for aging research across the life course funded by Nestlé Nutrition (Nestec Ltd), Metagenics Inc., and AXA. Nestlé Nutrition (Nestec Ltd.), Metagenics Inc. and AXA had no role in design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review or approval of the manuscript. MHO received a Research Grant from Merck & Co., Inc., West Point, PA. None of the other authors report conflicts of interest.

Figures

Figure 1
Figure 1
Shape of association of inflammation markers with common carotid artery intima-media thickness (CCA-IMT). Panel (a): baseline inflammatory markers and baseline CCA-IMT; panel (b): baseline inflammatory markers and yearly CCA-IMT progression; panel (c): change in inflammatory markers and yearly CCA-IMT progression. aModels in panel (c) were additionally adjusted for mean CCA-IMT. bModels in panels (a) and (b) were further adjusted for baseline traditional risk factors (i.e. systolic blood pressure, total cholesterol, history of diabetes, current smoking, use of anti-hypertensive medication), models in panel (c) for means and changes in traditional risk factors. hsCRP: high-sensitivity C-reactive protein; CI: confidence interval
Figure 2
Figure 2
Association of inflammation markers with common carotid artery intima-media thickness (CCA-IMT). Panel (a): baseline inflammatory markers and baseline CCA-IMT; panel (b): baseline inflammatory markers and yearly CCA-IMT progression; panel (c): change in inflammatory markers and yearly CCA-IMT progression. aModels in panels (a) and (b) were further adjusted for baseline traditional risk factors (i.e. systolic blood pressure, total cholesterol, history of diabetes, current smoking, use of anti-hypertensive medication), models in panel (c) for means and changes in traditional risk factors. The number of participants contributing to the analysis in panel (c) is less than in Table 1 because of missing values in the variables for which the analysis was adjusted. bModels in panel (c) were additionally adjusted for mean CCA-IMT. CI: confidence interval
Figure 3
Figure 3
Associations between number of elevated inflammation markers at baseline and common carotid artery intima-media thickness (CCA-IMT). Panel (a): baseline inflammatory load and baseline CCA-IMT; panel (b): baseline inflammatory load and yearly CCA-IMT progression. For each of the three inflammatory markers (high-sensitivity C-reactive protein, fibrinogen, leucocyte count), levels were deemed to be elevated if they were in the top two fifths of the study-specific distribution. People with no elevated inflammatory markers served as the reference group. Models were adjusted for baseline age, sex, systolic blood pressure, total cholesterol, history of diabetes, current smoking, and use of anti-hypertensive medication. CI: confidence interval

References

    1. Gardin JM, Bartz TM, Polak JF, et al. What do carotid intima-media thickness and plaque add to the prediction of stroke and cardiovascular disease risk in older adults? The cardiovascular health study. J Am Soc Echocardiogr. 2014;27:998–1005.e2. - PMC - PubMed
    1. Den Ruijter HM, Peters SAE, Anderson TJ, et al. Common carotid intima-media thickness measurements in cardiovascular risk prediction: A meta-analysis. JAMA. 2012;308:796–803. - PubMed
    1. Lorenz MW, Polak JF, Kavousi M, et al. Carotid intimamedia thickness progression to predict cardiovascular events in the general population (the PROG-IMT collaborative project): A meta-analysis of individual participant data. Lancet. 2012;379:2053–2062. - PMC - PubMed
    1. Baldassarre D, Nyyssönen K, Rauramaa R, et al. Cross-sectional analysis of baseline data to identify the major determinants of carotid intima-media thickness in a European population: The IMPROVE study. Eur Heart J. 2010;31:614–622. - PubMed
    1. Rundek T, Blanton SH, Bartels S, et al. Traditional risk factors are not major contributors to the variance in carotid intima-media thickness. Stroke. 2013;44:2101–2108. - PMC - PubMed

Publication types